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Genome replication of mammalian orthoreovirus (MRV) occurs in cytoplasmic inclusion bodies called viral factories. Nonstructural protein
μNS, encoded by genome segment M3, is a major constituent of these structures. When expressed without other viral proteins, μNS forms
cytoplasmic inclusions morphologically similar to factories, suggesting a role for μNS as the factory framework or matrix. In addition, most other
MRV proteins, including all five core proteins (λ1, λ2, λ3, μ2, and σ2) and nonstructural protein σNS, can associate with μNS in these structures.
In the current study, small interfering RNA targeting M3 was transfected in association with MRV infection and shown to cause a substantial
reduction in μNS expression as well as, among other effects, a reduction in infectious yields by as much as 4 log10 values. By also transfecting
in vitro-transcribed M3 plus-strand RNA containing silent mutations that render it resistant to the small interfering RNA, we were able to
complement μNS expression and to rescue infectious yields by ~100-fold. We next used μNS mutants specifically defective at forming factory-
matrix structures to show that this function of μNS is important for MRV growth; point mutations in a C-proximal, putative zinc-hook motif as
well as small deletions at the extreme C terminus of μNS prevented rescue of viral growth while causing μNS to be diffusely distributed in cells.
We furthermore confirmed that an N-terminally truncated form of μNS, designed to represent μNSC and still able to form factory-matrix
structures, is unable to rescue MRV growth, localizing one or more other important functions to an N-terminal region of μNS known to be
involved in both μ2 and σNS association. Thus, factory-matrix formation is an important, though not a sufficient function of μNS during MRV
infection; μNS is multifunctional in the course of viral growth.
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Mammalian orthoreovirus (MRV) is the type species of fa-
mily Reoviridae (reviewed in Schiff et al., 2007). MRV contains
ten genome segments of double-stranded RNA (dsRNA)–three
large (L), three medium (M), and four small (S)–enclosed within
a bilayered protein capsid that lacks a lipid envelope. Cell entry
results in delivery of the inner-capsid (“core”) particle into the⁎ Corresponding author. Department of Microbiology and Molecular
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doi:10.1016/j.virol.2008.02.024target cytoplasm. Once in the cytoplasm, the core particle begins
to transcribe the viral genome to produce full-length, capped
plus-strand RNAs ([+]RNAs) (Banerjee and Shatkin, 1970;
Levin et al., 1970; Skehel and Joklik, 1969), which can function
as mRNAs for the translation of viral proteins.
MRV replicates its genome in distinctive cytoplasmic in-
clusion bodies, often called viral factories (Gomatos, 1967;
Fields et al., 1971; Parker et al., 2002). These structures form
early in infection as small round inclusions, which then grow
larger and move toward the nucleus as infection proceeds. Later
in infection with most, but not all MRV strains, they are an-
chored to and spread along stabilizedmicrotubules (Dales, 1963;
Parker et al., 2002; Spendlove et al., 1963). Previous studies
have shown that the factories contain fully and partially as-
sembled viral particles, viral proteins, dsRNA, microtubules,
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(Dales, 1963, 1965; Fields et al., 1971; Spendlove et al., 1963;
Sharpe et al., 1982; Tournier and Plissier, 1960). Factories
appear not to contain ribosomes or membrane-bound compart-
ments, nor are they membrane-bound themselves (Gomatos,
1967; Rhim et al., 1962; Sharpe et al., 1982; Tournier and
Plissier, 1960). The localized sequestration and concentration of
viral RNAs, viral proteins, and cellular proteins is what defines
the viral factory, although the exact composition and functions of
the factory are only partially characterized.
The MRV nonstructural protein μNS comprises 721 amino
acid residues (80 kDa) and is encoded by genome segment M3
(McCrae and Joklik, 1978; Mustoe et al., 1978). Expression of
μNS in transfected cells is sufficient to form cytoplasmic in-
clusions morphologically similar to viral factories at low reso-
lution (Becker et al., 2003; Broering et al., 2002). We have
therefore hypothesized that μNS forms the factory framework or
“matrix” (for early use of this term, see Rhim et al., 1962;
Tournier and Plissier, 1960). Most other viral proteins, including
all five core proteins (λ1, λ2, λ3, μ2, and σ2) and nonstructural
protein σNS, have been shown to associate specifically and
independently with μNS in the factory-matrix structures (often
called factory-like structures, or FLS, in previous literature)
(Becker et al., 2003; Broering et al., 2002, 2004; Miller et al.,
2003, 2007). We have thus also hypothesized that μNS plays
further roles in recruiting such components to the factories.
These proteins may be individually or cooperatively involved in
RNA assortment, minus-strand synthesis, and core assembly.
After outer-capsid assembly, the transcriptional activity of
MRV core particles is repressed (Astell et al., 1972; Drayna and
Fields, 1982; Joklik, 1972; Yamakawa et al., 1982). When
complexed with μNS in vitro, outer-capsid proteins are prevented
from recoating the cores, which remain active for transcription
and capping despite the presence of μNS (Broering et al., 2000).
This suggests that μNS may also delay outer-capsid assembly
during infection so that larger amounts of [+]RNAs can be
produced by cores. Entering core particles can be localized to
factory-matrix structures (Broering et al., 2004), and during viral
infection the synthesis of viral RNA can be detected in the
factories (C.L. Miller and M.L.N., manuscript in preparation).
A second form of μNS, called μNSC, lacks about 5 kDa from
its N terminus and is routinely detected in infected cells (Lee et al.,
1981; Wiener et al., 1989). It appears to be an independent
translation product of M3, resulting from initiation at Met41
(instead of Met1) in the μNS sequence (McCutcheon et al., 1999;
Wiener et al., 1989). The role of μNSC in viral infection has not
been determined, but a recent report has provided evidence that
expression of μNSC is neither necessary nor sufficient to support
MRV growth in cell culture (Kobayashi et al., 2006).
Rotavirus also forms non-membrane-bound cytoplasmic
inclusion bodies, commonly called viroplasms, which appear
similar to MRV factories (Petrie et al., 1984). Nonstructural
proteins NSP2 and NSP5 are needed in combination to form
viroplasm-like structures, or VLS, in transfected cells (Fabbretti
et al., 1999). A number of studies with rotavirus have described
the silencing of viral protein expression with small interfering
RNAs (siRNAs), often accompanied by effects on viral growth(reviewed by Arias et al., 2004). Silencing of either NSP2 or
NSP5 expression, for example, inhibits several events in the
viral life cycle, including formation of viroplasms and genome
replication (Campagna et al., 2005; Lopez et al., 2005; Silvestri
et al., 2004). Complementation with NSP2 expressed in trans
after silencing of the virus-produced transcripts has been addi-
tionally useful in the study of NSP2 functions during rotavirus
infection, rescuing virion assembly by ~6-fold (Taraporewala
et al., 2006).
More recently, a complementation system for MRV μNS has
been shown to rescue viral growth by ~40-fold after M3 silencing
by siRNA (Kobayashi et al., 2006). That system has used cell
lines stably expressing a short hairpin RNA against M3/μNS to
knock down protein expression and has shown that infectious
yields ofMRVcan be diminished byN3 log10 values. Importantly,
that study has been the first to provide direct evidence that μNS is
an “essential” protein for MRV growth, but did not specifically
probe whether formation of factory-matrix structures is one of its
important properties.
We have hypothesized that μNS plays a central role in the
formation of functional viral factories (Broering et al., 2000,
2002, 2004; Miller et al., 2003, 2007), and in this study we
tested some of its important properties for MRV growth. We
first knocked down μNS expression using siRNA. In the ab-
sence of high levels of μNS expression, viral growth was in-
hibited. We then developed a system to rescue MRV growth by
complementing with in vitro-transcribed M3 [+]RNA that ex-
pressed μNS in the presence of siRNA. We were able to rescue
infectious yields by ~100-fold with this method of μNS trans-
expression. The complementation system then allowed us to test
μNS mutants specifically defective at forming factory-matrix
structures, and we were thereby able to show that this function
of μNS is important for rescuing viral growth. In addition, we
confirmed that expression of an N-terminally truncated form of
μNS, designed to represent μNSC and still able to form factory-
matrix structures, is unable to rescue MRV growth, localizing
one or more other important functions of μNS to its N terminus.
Thus, factory-matrix formation is an important, though not a
sufficient function of μNS during MRV infection.
Results
M3-targeting siRNAs reduce μNS expression in a
strain-dependent manner
To reduce the expression of μNS during MRV infection,
three different siRNAs (M3-si01, M3-si02, and M3-si03) were
designed to target the M3 [+]RNA encoding μNS with the
following strain specificities (Figs. 1a, b). M3-si01 and M3-si02
were designed to target strains Type 1 Lang (T1L) and Type 3
Dearing (T3D). M3-si03, in comparison, was designed to target
only T3D, since T1L has two nucleotide mismatches with the
M3-si03 sequence. None of the three siRNAs were designed to
target strain Type 2 Jones (T2J), since T2J has two or more
nucleotide mismatches with each of the M3-si sequences.
To test the ability of each siRNA to knock down μNS expres-
sion, the siRNAswere individually transfected by electroporation
Fig. 1. siRNAs targeting MRV M3 transcripts. (a) Schematic of the M3 gene
depicting locations of the siRNA target sequences in MRV strains T1L, T2J, and
T3D. Nucleotides 194–212 of T1L and T3D are targeted by M3-si01 (1).
Nucleotides 140–158 of T1L and T3D are targeted by M3-si02 (2). Nucleotides
1369–1387 of T3D are targeted by M3-si03 (3). (b) Sequences of the three M3-
targeting siRNAs are shown, each followed by the corresponding region of the
T1L, T2J, and T3DM3 genes. Mismatches between siRNA and gene are in bold
and overlined in the gene sequence.
Fig. 2. Viral protein expression and dsRNA production in siRNA-transfected
cells. CV-1 cells were transfected by electroporation with either no siRNA,
control siRNA, M3-si01, M3-si02, or M3-si03 as indicated in each panel. The
cells were infected with MRV strain T1L, T2J, or T3D at 24 h p.t. at an MOI of
5. (a–c) Cells were harvested at 24 h p.i. by washing with PBS and then lysing in
2× sample buffer. Lysates were boiled for 5 min, separated by SDS/PAGE,
transferred to nitrocellulose, and immunoblotted with polyclonal μNS antiserum
(a) or polyclonal T1L virion antiserum (b). GAPDH immunoblot (c) was in-
cluded as a loading control. (d) Cells were harvested at 24 h p.i. by washing with
PBS and then purifying total RNA by TrizolLS extraction. Samples were heated
to 60 °C for 5 min, and dsRNAs (large, L; medium,M; and small, S as indicated)
were resolved by SDS/PAGE. The gel was stained with 0.5% ethidium bromide.
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infected with purified stocks of MRV T1L, T2J, or T3D at a
multiplicity of infection (MOI) of 5 PFU/cell. At 24 h post-
infection (p.i.), whole-cell lysates were collected, separated by
SDS/polyacrylamide gel electrophoresis (SDS/PAGE), trans-
ferred to nitrocellulose, and probed with anti-μNS polyclonal
antibodies (Fig. 2a). In the case of T1L infection, similarly
strong expression of μNS was observed in cells that were
electroporated without siRNA, cells that received an irrelevant
control siRNA, and cells that received M3-si03, which did not
target T1L M3. M3-si01 and M3-si02, however, reduced μNS
expression to near (M3-si02) or below (M3-si01) the limit of
detection, consistent with the fact that they both targeted T1L.
In the case of T2J infection, similar levels of μNS expression
were observed regardless of the treatment, consistent with the
fact that none of the siRNAs targeted T2J M3. In the case of
T3D infection, all three siRNAs reduced μNS expression when
compared to the two types of control-treated cells, consistent
with the fact that they all targeted T3D M3. The relative
efficacies of the three siRNAs at reducing μNS expression by
T3D appeared to be M3-si01NM3-si03NM3-si02. By demon-
strating the expected strain specificities with the three different
siRNAs, the results show that the primary effect of each siRNA
was on the respective M3 [+]RNA.
M3-targeting siRNAs reduce expression of other viral proteins
and production of viral dsRNAs
To investigate the effect of reduced μNS expression on other
MRV proteins, the whole-cell lysates from the same represen-tative experiment as described in the preceding section were
also examined by immunoblotting with anti-virion polyclonal
serum. In each of the samples that had been treated with siRNA
that targeted M3 in a strain-dependent manner, there was also a
substantial corresponding reduction in the expression of other
viral proteins (Fig. 2b and data not shown). To determine the
effect of M3 [+]RNA silencing on MRV genome replication, we
examined viral dsRNA levels. RNAwas extracted from cells of
the same representative knockdown experiment, separated by
SDS/PAGE, and visualized by ethidium bromide staining. Viral
dsRNA production was inhibited by treatment with siRNA in a
strain-dependent manner: M3-si01 and M3-si02 both effec-
tively targeted T1L and T3D, whereas M3-si03 effectively tar-
geted T3D only (Fig. 2d). The most effective siRNA at reducing
levels of both viral proteins and viral dsRNAs in cells was M3-
si01. From these experiments, we conclude that efficient
Fig. 3. Viral titers in siRNA-transfected cells. CV-1 cells were transfected by
electroporation with either no siRNA (N), control siRNA (C), M3-si01 (1), M3-
si02 (2), or M3-si03 (3) as indicated in each panel. The cells were infected with
MRV strain T1L (a), T2J (b), or T3D (c) at 24 h p.t. at an MOI of 5. Cells were
then harvested by freeze–thaw at the times specified in each panel, and
infectious viral titers were determined by plaque assays on L929 cells. This
figure is representative of three independent experiments.
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other MRV proteins and efficient replication of the MRV ge-
nome. Due to the amplification of MRV protein and genome
synthesis that results from transcript production by nascent
cores (Murray and Nibert, 2007; Zarbl and Millward, 1983), we
cannot yet identify whether μNS knockdown primarily affects
the function of entering (i.e., parental) cores and their transcripts
and/or the assembly and function of nascent (i.e., progeny)
cores; however, we favor the hypothesis that μNS provides
important functions for both entering and nascent cores (see
Discussion).
M3-targeting siRNAs reduce infectious viral titers
To test for their abilities to knock down viral titers, the
siRNAs were individually transfected by electroporation into
CV-1 cells. At 24 h p.t., the cells were infected with purified
virions of MRV T1L, T2J, or T3D at an MOI of 5 PFU/cell. At
0, 24, and 48 h p.i., infectious viral titers were then determined
by plaque assay. In the case of T1L infection (Fig. 3a), a N2-
log10 increase in viral titer was seen at 24 h p.i. in control cells
that were electroporated without siRNA, as well as in control
cells that received an irrelevant siRNA. A similar increase in
viral titer was also seen in cells that received the M3-specific
siRNA that did not target T1L, M3-si03. In contrast, the two
M3-specific siRNAs that targeted T1L, M3-si01 and M3-si02,
reduced viral titers to near input (0-h) levels. Similar, respective
effects of the different treatments on titers of T1L were seen at
48 h p.i. In the case of T2J infection (Fig. 3b), a similar increase
in viral titer (N1 log10 at 48 h p.i.) was seen regardless of the
treatment, as expected since none of the three M3-specific
siRNAs target T2J (Note that T2J is known to have lower
infectious yields than T1L or T3D (Ahmed et al., 1981).). In the
case of T3D infection (Fig. 3c), all three M3-specific siRNAs
reduced viral titers to near input levels, as expected since all
three siRNAs target T3D. The most effective siRNA at reducing
the titers of both T1L and T3D was M3-si01, which in multiple
experiments restricted viral titers to near input levels.
In summary, the results of these experiments with siRNAs
indicate strong knockdown of infectious yields of MRVs T1L
and T3D in a strain-dependent manner consistent with
sequence-specific targeting of the viral M3 [+]RNA. In the
case of M3-specific siRNAs that did not target particular strains
(T1L by M3-si03 and T2J by M3-si01, M3-si02, M3-si03), as
well as the irrelevant siRNA, the lack of effect on infectious
yields provide evidence that any off-target effects of these
siRNAs have little impact on MRV growth.
Complementation of μNS expression and rescue of viral growth
For both T1L and T3D infection, M3-si01 showed stronger
effects than the other siRNAs. For this reason, we performed
subsequent experiments with M3-si01 only. We endeavored to
study properties of μNS in the context of MRV infection by
designing a system to rescue viral growth upon expression of
μNS in trans from M3 [+]RNA that would not be targeted by
M3-si01.A previous report has shown that transfection of MRV cores
can be a useful method to infect cells, bypassing the entry steps
(Jiang and Coombs, 2005). When a cell line derived from baby
hamster kidney cells, BSR-T7 (Buchholz et al., 1999), was
transfected with cores alone, the virus replicated to higher titers
than in CV-1 cells (Fig. 4a, lane A, and data not shown). When
M3-si01 was cotransfected with T1L cores, infection was in-
hibited in a similar manner to that seen when siRNA-pretreated
cells were subsequently infected with virions (compare Fig. 4a,
lane B, with Fig. 2a, bar 1). Following core transfection in BSR-
T7 cells, however, knockdown of infectious yields in the pr-
esence of M3-si01 was even more substantial, resulting in an
~4-log10 decrease in viral titer. We next generated in vitro-
Fig. 5. Rescue of viral growth with μNS mutants, part 1. BSRT7 cells were
transfected using Lipofectamine 2000. Lanes reflect different combinations of
transfected materials as follows: (A) T1L cores alone; (B) T1L cores andM3-si01;
(C) T1L cores, M3-si01, and mutRNA expressing wild-type μNS as in Fig. 4;
(D) T1L cores, M3-si01, and mutRNAwith point mutation C561S; (E) T1L cores,
M3-si01, and mutRNAwith point mutation H569Q; (F) T1L cores, M3-si01, and
mutRNAwith point mutation H570Q; and (G) T1L cores, M3-si01, and mutRNA
with point mutation C572S. Cells were harvested at 24 h p.i. for viral titers (a) and
protein analyses (b–d) as described for Fig. 4. Titers were expressed as infectious
yields relative to that of the cores+M3-si01 sample within each replicate
experiment, and the relative yields from three such experiments are shown as the
mean±standard deviation for each type of sample. The blots are representative of
the three experiments.
Fig. 4. Complementation of μNS with in vitro-transcribed M3 [+]RNA. BSRT7
cells were transfected using Lipofectamine 2000. Lanes reflect different
combinations of transfected materials as follows: (A) T1L cores alone; (B)
T1L cores, M3-si01, and in vitro-transcribed M3 [+]RNA expressing wild-type
T1L μNS; and (C) T1L cores, M3-si01, and in vitro-transcribed M3 [+]RNA
expressing wild-type T1L μNS but also containing silent mutations in the
siRNA target sequence (mutRNA). Cells were then harvested at 24 h p.i. for
viral titers and protein analyses. For titers (a), cells were harvested by freeze–
thaw, and plaque assays were performed on L929 cells. Titers were expressed as
infectious yields relative to that of the cores+M3-si01 sample (not shown in this
figure) within each replicate experiment, and the relative yields from two such
experiments are shown as adjacent bars for each type of sample. For protein
analyses (b–d), cells were harvested by washing with PBS and then lysing in 2×
sample buffer. Lysates were boiled for 5 min, separated by SDS/PAGE,
transferred to nitrocellulose, and immunoblotted with polyclonal μNS antiserum
(b) or T1L virion antiserum (c). GAPDH immunoblot (d) was included as a
loading control. The blots are representative of the two experiments.
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three silent nucleotide changes in the siRNA target sequence
(see Materials and Methods). Cotransfections with cores, M3-
si01, and this siRNA-resistant rescue RNA (henceforth called
mutRNA) resulted in increased expression of μNS (Fig. 4b, lane
C), increased expression of other viral proteins (Fig. 4c, lane C),
and ~2-log10 rescue of infectious yields (Fig. 4a, lane C). In
contrast, cotransfections including instead the siRNA-sensitive
wild-type M3 [+]RNA did not rescue infectious yields (Fig. 4a,
lane B). Increasing the transfected amount of mutRNA did
not increase μNS expression or viral titers (data not shown).
Though we were unable to rescue the full 4 log10 values of
infectious yield that were lost with siRNA treatment, we con-
clude that the level of rescue we do observe with mutRNA is
sufficient to ascertain the effects of mutations in μNS.Putative zinc-hook residues His570 and Cys572 are important
for rescuing viral growth
A previous report from our lab has shown that μNS residues
His570 and Cys572 are each important for formation of
factory-matrix structures; when these two residues are
individually mutated and the μNS proteins are then transiently
expressed in cells, μNS is diffusely distributed throughout
the cell when observed by immunofluorescence microscopy
(Broering et al., 2005). In contrast, mutation of other Cys and
His residues flanking this region does not disrupt formation of
these structures. To test the importance of these Cys and His
residues in the context of MRV infection, we used our siRNA-
complementation system. We generated constructs encoding
single mutations at residues Cys561 (to Ser), His569 (to Gln),
His570 (to Gln), or Cys572 (to Ser) within the μNS rescue
plasmid, which were then used to generate in vitro-transcribed
M3 [+]RNAs (mutRNAs). Point mutations C561S and H569Q
still allow μNS to form factory-matrix structures when transiently
expressed (Broering et al., 2005). These same two mutants tested
in our siRNA-complementation system rescued infectious yields
similarly to wild-type μNS (Fig. 5a, lanes C–E). The transfected
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munoblot (Fig. 5b, lanes C–E) and also rescued expression of
other viral proteins to similar levels (Fig. 5c, lanes C–E). We
furthermore confirmed by immunofluorescence microscopy that
the factories formed in rescued cells were similar to the factories
in wild-type infection, although smaller in size (Figs. 6d and e).
On the other hand, point mutations H570Q and C572S disrupted
formation of factory-matrix structures as expected (Broering
et al., 2005), causing μNS to be diffused in cells (Figs. 6f and g).Fig. 6. Immunofluorescence microscopy of viral factories during rescue of viral
growth with mutants of μNS. BSRT7 cells were transfected using Lipofectamine
2000 and then fixed at 24 h p.t. for immunostaining. The cells were immunostained
with anti-μNS IgG followed by goat anti-rabbit IgG conjugated to Alexa 488.
Images reflect different combinations of transfected materials as follows: (a) T1L
cores alone; (b) T1L cores and M3-si01; (c) T1L cores, M3-si01, and mutRNA
expressing wild-type μNS as in Fig. 4; (d) T1L cores, M3-si01, and mutRNAwith
point mutation C561S; (e) T1L cores, M3-si01, and mutRNAwith point mutation
H569Q; (f) T1L cores,M3-si01, andmutRNAwith pointmutationH570Q; (g) T1L
cores, M3-si01, and mutRNAwith point mutation C572S; (h) T1L cores, M3-si01,
and mutRNA expressing μNS(1–713); (i) T1L cores, M3-si01, and mutRNA
expressing μNS(1–719); (j) T1L cores, M3-si01, and mutRNA expressing μNS
(41–721) (μNSC alone); and (k) T1L cores, M3-si01, and mutRNA expressing
μNS(1–721) (μNS alone).Neither of these two mutants was able to rescue infectious yields
(Fig. 5a, lanes F and G) or expression of other viral proteins
(Fig. 5c, lanes F and G), even though the transfected mutRNAs
expressed similar levels of μNS as compared to those in other
rescue conditions (Fig. 5b, lanes C–G). These data provide direct
evidence that the ability of μNS to form the factory matrix is
important for MRV growth.
Within the minimal contiguous region of μNS sufficient for
forming factory-matrix structures in transfected cells (residues
471–721) (Broering et al., 2005), there are five additional Cys and
His residues (Cys488,His489, Cys491, Cys608, andCys619) that
previously had not been examined by mutagenesis. We therefore
examined these other sites as a part of the current study, making a
Ser substitution for each Cys and a Gln substitution for each His.
When each of these mutants was expressed in transfected cells,
factory-matrix structures formed that were indistinguishable from
those formed by wild-type μNS (data not shown). These results
further highlight the specific importance of Cys570 and His572 in
formation of the factory matrix.
Extreme C terminus of μNS is important for rescuing viral
growth
C-terminally truncated μNS proteins are also diffusely dis-
tributed in the cytoplasm of transfected cells (Broering et al.,
2005). We have thereby shown that some portion of residues
714–721 is important for formation of factory-matrix structures.
To examine further our hypothesis that this function of μNS is
required for MRV growth, we generated rescue plasmids to
express μNS residues 1–713 or 1–719. We then used these
plasmids to generate in vitro-transcribed M3 [+]RNAs (mutR-
NAs) as in preceding experiments. Neither of these C-terminal
truncation mutants, when tested in our siRNA-complementation
system, rescued infectious yields (Fig. 7a, lanes D and E) or
expression of other viral proteins (Fig. 7c, lanes D and E), even
though the transfected mutRNAs expressed similar levels of
μNS as that expressing wild-type μNS (Fig. 7b, lanes C–E). We
also confirmed by immunofluorescence microscopy that μNS
(1–713) and μNS(1–719) expressed during rescue was diffuse
in cells (Fig. 6h and i). These findings further support our
hypothesis that the ability of μNS to form the factory matrix is
important for MRV growth. The inability of μNS(1–719) to
form factory-matrix structures and to rescue MRV growth in-
dicates that one or both of the last two residues of μNS, Glu720
Fig. 8. Expression of μNSC in the absence of μNS is unable to rescue viral
growth. BSRT7 cells were transfected using Lipofectamine 2000. Lanes reflect
different combinations of transfected materials as follows: (A) T1L cores alone;
(B) T1L cores and M3-si01; (C) T1L cores, M3-si01, and mutRNA expressing
wild-type μNS (and μNSC) as in Fig. 4; (D) T1L cores, M3-si01, and mutRNA
expressing μNSC only (ΔAUG1); and (E) T1L cores, M3-si01, and mutRNA
expressing full-length μNS only (ΔAUG2). Cells were harvested at 24 h p.i. for
viral titers (a) and protein analyses (b–d) as described for Fig. 4. Titers were
expressed as relative yields as described for Fig. 5. The blots are representative
of the three replicate experiments.
Fig. 7. Rescue of viral growth with μNS mutants, part 2. (a–d) BSRT7 cells
were transfected using Lipofectamine 2000. Lanes reflect different combina-
tions of transfected materials as follows: (A) T1L cores alone; (B) T1L cores
and M3-si01; (C) T1L cores, M3-si01, and mutRNA expressing wild-type μNS
as in Fig. 4; (D) T1L cores, M3-si01, and mutRNA expressing μNS(1–713); and
(E) T1L cores, M3-si01, and mutRNA expressing μNS(1–719). Cells were
harvested at 24 h p.i. for viral titers (a) and protein analyses (b–d) as described for
Fig. 4. Titers were expressed as relative yields as described for Fig. 5. The blots
are representative of the three replicate experiments. (e) The C-terminal eight
residues of μNS homologs frommammalian reoviruses (MRV), avian reoviruses
(ARV), and aquareoviruses (AqRV NS1). Sequence variation between strains
within each group of viruses is indicated by stacked letters. The C-terminal eight
residues of viroplasm-forming protein NSP5 from group A rotavirus strains
SA11 and RRVare also shown.
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A C-terminal Leu residue is conserved among the μNS proteins
of mammalian and avian reoviruses (McCutcheon et al., 1999;
Su et al., 2006; Zhang et al., 2007) as well as the μNS sequence
homolog, NS1, of aquareoviruses (Attoui et al., 2002) (Fig. 7e),
suggesting that it may be particularly important.
μNSC in the absence of μNS is unable to rescue viral growth
We additionally used our siRNA-complementation system
to examine the role of the μNS N terminus in MRV infection.
N-terminal truncations of μNS retain the ability to form factory-
matrix structures but no longer associate with certain other MRV
proteins (Broering et al., 2002, 2005; Miller et al., 2003, 2007).
We generated a construct to express μNS residues 41–721, de-
signed to represent μNSC (Lee et al., 1981; McCutcheon et al.,1999; Wiener et al., 1989), by changing the start codon of full-
length μNS, Met1, to Lys (ΔAUG1). We also generated a
construct to express full-length μNS alone, by changing the
apparent start codon of μNSC, Met41, to Leu (ΔAUG2). These
single point mutations were made in the siRNA-resistant rescue
plasmid, from which we then generated in vitro-transcribed M3
[+]RNAs (mutRNAs). The expected translation products of these
constructs were confirmed by immunoblot (Fig. 8b). We
furthermore confirmed by immunofluorescence microscopy that
both μNS(ΔAUG1) (i.e., μNSC alone) and μNS(ΔAUG2) (i.e.,
μNS alone), expressed during rescue, formed morphologically
similar factories or factory-matrix structures (Fig. 6j and k).
Expression of μNSC alone, however, was unable to mediate
rescue of MRV growth, as both infectious yields and expression
of other MRV proteins remained as low as in the control M3-si01
knockdown (Fig. 8a and c, lanes B and D). Thus, the ability to
form the factory matrix is not a sufficient function of μNS for
rescue in this system. In contrast, expression of full-length μNS
alone rescued both infectious yields and expression of other viral
proteins as well as did μNS/μNSC expression from the wild-type
μNS rescue RNA (mutRNA) (Fig. 8a and c, lanes C and E),
providing evidence that μNSC is not required for rescue of viral
growth in this system.
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Since M3 [+]RNAs with authentic 5′ and 3′ ends, as well as
a 5′ cap, were used for rescue in the described experiments, it is
possible that these RNAs were packaged into nascent MRV core
particles, and then infectious virions. Screening for in vitro-
derived, mutant M3 RNA in rescued clones is underway; how-
ever, since knockdown by siRNA was not 100% efficient, the
background of virus-derived, wild-type M3 RNA may be high
in comparison to any potential packaging of rescue RNA. In
addition, the MRV factories (and rotavirus viroplasms) are pro-
posed to protect virus-derived [+]RNAs from degradation by
the RNA-interference pathway (Arias et al., 2004; Carvalho
et al., 2007; Silvestri et al., 2004), giving virus-derived RNAs
an advantage for replication and packaging. To date, of the
rescued clones that we have screened by restriction digest after
cDNA amplification of the M3 gene, all have had wild-type M3
(M.M.A. and M.L.N., unpublished data). Thus, rescue in this
system appears largely to occur through gene-specific com-
plementation of viral protein expression, as also suggested by
previous related studies with MRV and rotavirus (Carvalho
et al., 2007; Kobayashi et al., 2006; Taraporewala et al., 2006).
By testing numerous variables when establishing the siRNA-
complementation system to study μNS functions, we identified
an optimal approach that involved cotransfection of MRV cores,
siRNA targeting core-transcribed M3 [+]RNA, and in vitro-
transcribed M3 [+]RNA containing silent mutations that render
them resistant to the siRNA (mutRNA). Attempts to rescue
MRV growth with a cotransfected μNS-expression plasmid were
not as successful; we repeatedly observed an increase in in-
fectious yields of only ~10-fold in those experiments (data not
shown), versus ~100-fold with our optimal protocol. Notably,
μNS expression from cotransfected plasmid was consistently
lower than that from cotransfected M3 [+]RNA (data not
shown). Increasing the amount of cotransfected plasmid did not
much improve μNS expression, as more plasmid appeared toxic
to the cells. We interpret these findings to indicate that the level
of rescue correlates with the level of μNS expression, and that
plasmid-based expression was less efficient in our hands. M3 is
the second most efficiently translated reovirus mRNA, after S4
(Gaillard and Joklik, 1985), so it is perhaps not surprising that
the extent of rescue with this general approach depends on the
level of μNS expression. Kobayashi et al. (2006) also report only
~40-fold rescue of infectious yields upon trans-expression of
μNS, albeit from transfected plasmid in their system.
M3-targeting siRNAs in these experiments were able to
reduce infectious yields by as much as 4 log10 values. So why
was only 10- to 100-fold rescue of yields then achieved by μNS
trans-expression? Optimal levels of μNS expression achieved
even with cotransfected M3 [+]RNA in our hands were still
lower than that in control infections (see Figs. 4–8). Thus, in-
efficient rescue could simply reflect that insufficient μNS was
expressed. Another interesting explanation, however, could re-
late to the specific localization of μNS expression within the
cell, especially as pertains to early steps in infection. Entering
MRV core particles may need to be embedded within a μNS
matrix soon after infection in order for (i) newly core-transcribed[+]RNAs to be retained in the viral factory and made properly
available for genome replication and assembly of nascent cores
and/or (ii) entering cores not to be prematurely recoated by
newly synthesized outer-capsid proteins and thereby transcrip-
tionally inhibited (Broering et al., 2000, 2004; Miller et al.,
2003). If μNS from M3 transcripts made by an entering core is
poorly expressed due to siRNA knockdown, there may be
insufficient μNS in close proximity to the core to embed it
effectively and thereby to trap the newly core-transcribed
[+]RNAs. Moreover, complementing μNS from trans-expressing
M3 [+]RNA molecules may not be able to reproduce this lo-
calized expression as effectively as core-made M3 transcripts.
This type of spatial requirement for trans protein to be produced
near entering virus particles has been convincingly shown for
flock house virus (Venter et al., 2005), and we have also provided
some related evidence in this regard in a recent study of MRV μ2
protein (Carvalho et al., 2007).
Some toxicity of transfected [+]RNA may also contribute to
limiting the extent of rescue. This effect is evident in Figs. 4, 5, 7,
and 8, inwhich noncomplementingM3 [+]RNAs produced yields
below those of the standardization control (transfection with
cores+M3-si01, but no M3 [+]RNA). These results might alter-
natively indicate that the μNS mutants expressed from non-
complementing mutRNAs in Figs. 5, 7, and 8 had a dominant-
negative effect on viral growth; however, because the same effect
was seen with noncomplementing wild-type M3 [+]RNA in
Fig. 4, we favor RNA toxicity as the probable explanation.
Transfecting with cores versus infecting with virions is an-
other distinctive part of our optimal protocol. We believe that the
benefit in this case was to reduce the background of infectious
particles present at early times of infection (e.g., in time-0
samples), so that a greater growth differential could then be seen
over a single infectious cycle. Thus, though not an essential part
of the protocol (data not shown), the use of transfected cores to
initiate infection helped to improve the extent of both knock-
down and rescue that we could recognize.
Having established our siRNA-complementation system for
rescue of infectious yields, we then used it to study specific
properties of μNS that had been identified and localized in
previous studies (Becker et al., 2003; Broering et al., 2000, 2002,
2004, 2005; Miller et al., 2003, 2007), but not yet directly
correlated with effects during MRV infection. First, we ad-
dressed whether ability to form the factorymatrix is an important
function of μNS for MRV growth. Our model based on previous
results has held this to be the case, but direct evidence from our
studies has been lacking. Neither do the results of Kobayashi
et al. (2006) address this question directly through the use of
pertinent μNS mutants. In the current study, we used μNS
mutants which, according to our previous characterizations
(Broering et al., 2005) and confirmed in this study (see Fig. 6),
have specific defects in forming the factory matrix. By showing
that these mutants were unable to rescue infectious yields in our
siRNA-complementation system, while nonetheless being ex-
pressed to levels similar to wild-type μNS (see Fig. 5), we
provided strong evidence that formation of the factory matrix
per se is an important function of μNS for MRV growth. As
suggested in Results, our findings do not yet identify when in the
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role(s), whether on the function of entering cores and their
transcripts and/or on the assembly and function of nascent cores;
thus, future studies will be needed to address our hypothesis that
the μNS-formed factory matrix provides important functions for
both entering and nascent cores (Broering et al., 2000, 2004;
Miller et al., 2003).
The preceding evidence that formation of the factory matrix
per se is an important function of μNS for MRV growth extends
to two separate small regions of μNS that have been implicated
in matrix formation: (i) a putative zinc-hook motif at residues
His570 and Cys572 and (ii) the extreme C terminus, now fur-
ther localized to the last two residues, Asp720 and/or Leu721
(Broering et al., 2005; this study). We expect that a number of
different types of μNS–μNS interactions are needed to build the
large three-dimensional matrix of the viral factories and that
these two small regions of μNS (570/572, 720/721) may each be
directly involved in one or more of these interactions. In any
case, the rescue results presented here provide evidence that both
of these regions are important for forming a factory matrix that is
functional to support MRV growth. A potentially related
observation is that the C-terminal residues of viroplasm-forming
protein NSP5 of many rotavirus strains (e.g., Fabbretti et al.,
1999; Sen et al., 2007) are quite similar to those of mammalian
and avian reoviruses, including the terminal Leu (see Fig. 7e).
Using our siRNA-complementation system to study specific
properties of μNS that had been identified and localized in
previous studies (Becker et al., 2003; Broering et al., 2000,
2002, 2004, 2005; Miller et al., 2003, 2007), but not yet directly
correlated with effects during MRV infection, we addressed,
too, whether any of the MRV protein-association activities of
μNS is also an important function for MRV growth. Our model
based on previous results has again held this to be the case, but
evidence has again been limited. In this case, though, the results
of Kobayashi et al. (2006) have addressed this question directly;
trans-expression of μNSC was unable to rescue infectious
yields even while being expressed to levels similar to wild-type
μNS. We have now been able to reproduce this finding in our
system (see Fig. 8). Our previous results have shown that two
other MRV proteins, μ2 and σNS, associate with μNS, but not
μNSC; thus, though μNSC forms factory-matrix structures, it
cannot recruit these two viral proteins to them (Broering et al.,
2002; Miller et al., 2003). Based on the current results, we
therefore conclude that during infection there is a specific
importance for one or both of these proteins, μ2 and σNS, to be
recruited to the viral factories through association(s) with μNS.
Our findings do not yet identify when in the viral infectious
cycle either of these two recruitment activities of μNS is playing
its important role(s); thus, future studies will be needed to
address the hypothesis that recruitment of μ2 and/or σNS is
important for core-transcribed [+]RNAs to be retained in the
viral factory and made properly available for genome replica-
tion and assembly of nascent cores (Broering et al., 2000, 2004;
Carvalho et al., 2007; Kobayashi et al., 2006; Miller et al.,
2003). Indeed we further hypothesize that other MRV protein-
association activities of μNS, which have been mapped to μNS
regions C-terminal to Met41 (Broering et al., 2000, 2004; Milleret al., 2007; C.L.M. and M.L.N., manuscript in preparation), are
also important functions of this multifunctional protein, and we
expect to test this hypothesis in other future studies. In the
meantime we can conclude that the function of μNS to form the
factory matrix is not all that it does to support MRV growth;
factory-matrix formation is an important, though not a
sufficient function of μNS during MRV infection.
Materials and methods
Cells and viruses
BSR-T7 cells are derived from baby hamster kidney cells
(Buchholz et al., 1999). BSR-T7 and CV-1 cells were main-
tained in Dulbecco's modified Eagle's medium (DMEM) (Invi-
trogen) containing 10% fetal bovine serum (HyClone). Spinner-
adapted mouse L929 cells were grown in Joklik's modified
minimal essential medium (Sigma-Aldrich) supplemented to
contain 2% fetal bovine serum and 2% bovine calf serum
(HyClone) in addition to 2mMglutamine, 100 U of penicillin/ml,
and 100 μg of streptomycin/ml (Mediatech). Reovirus strains
T1L, T2J, and T3D were lab stocks originating from the Bernard
N. Fields lab. Purified virions were grown in L929 cells and
purified as described elsewhere (Nibert and Fields, 1992).
Cores were prepared as previously described (Chandran et al.,
1999).
Antibodies and other reagents
Rabbit polyclonal antisera against μNS protein and T1L
virions have been described previously (Broering et al., 2000;
Virgin et al., 1988). GAPDH antibody was purchased from
Santa Cruz Biotech. Horseradish peroxidase-conjugated goat
anti-mouse IgG (KPL) or goat anti-rabbit IgG (Pierce) were
used as secondary antibodies. Restriction enzymes were ob-
tained from New England Biolabs.
siRNAs
All siRNAs were purchased from Dharmacon. The
μNS siRNA target sequences are as follows: M3-si01 is 5′-
UACCUUAUCAGCAUGUGAAdTdT-3′, M3-si02 is 5′-
UGUCUCAAUCGCGUGAAUUdTdT-3′, and M3-si03 is 5′-
AUGUGCUACUAUCAUCCUUdTdT-3′. The control siCTRL
is the non-targeting siRNA #1 from Dharmacon (siCONTROL).
The siRNAs were resuspended according to the manufacturer's
instructions to a concentration of 40 μM, and used at a final
concentration of 100 nM.
Mammalian expression vectors
Plasmid pBOS36 was constructed to serve as the transcrip-
tion template for in vitro RNA synthesis. To generate a cDNA
copy of the MRV T1L M3 gene, total RNA was obtained from
MRV-infected L929 cells using TrizolLS reagent according to
the manufacturer's instructions (Invitrogen). Purified RNAwas
used as a template for M3 cDNA synthesis. M3 cDNA was
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(Invitrogen) and the reverse primer 5′-GATGAATAGG-
GGTCGGG-3′. The first strand cDNA was PCR-amplified
using PfuI Turbo (Stratagene) and the two primers M3-SacI(for)
5 ′ -GGGGGGGAGCTCGCTAAAGTGACCGTGGT-
CATGGC-3′ and M3-MluI(rev) 5′-CCCCCCACGCGTGAT-
GAATAGGGGTC GGG-3′, which added a 5′ SacI site and a 3′
MluI site onto the M3 cDNA. Following PCR amplification, the
M3 cDNA was purified, SacI/MluI digested, and ligated into
vector pET21B+ (Novagen) immediately downstream from the
T7 promoter. A cDNA copy of the hepatitis delta virus ribozyme
was PCR-amplified from a pCI-neo construct provided by Dr.
Cathy L. Miller (C.L.M. and M.L.N., unpublished data) and
ligated into the pET21B+ vector using the MluI site and a NotI
site. To allow for the synthesis of M3 [+]RNAs possessing an
authentic 5′ terminus, the SacI restriction site sequence was
removed by site-directed mutagenesis using the two primers
pBOS36-SacI(for) 5′-CGACTCACTATAGGCTAAAGT-
GACCGTGGTCATGGC-3′ and pBOS36-SacI(rev) 5′-CA-
CGGTCACTTTAGCCTATAGTGAGTCGTATTAATTTCGC-
GG-3′, which juxtaposed the T7 promoter and the +1 nucleotide
of M3. Likewise the MluI site was removed from the 3′ end of
the M3 sequence by site-directed mutagenesis using primers
p BOS 3 6 -M l u I ( f o r ) 5 ′ - GGCTAAGGGAGAGC -
TGCGGCCGCCTCGAGCACCACC-3′ and pBOS36-MluI
(rev) 5′-GGTGCTCGAGGCGGCCGCAGCTCTCCCTTA-
GCCATCCG-3′, which allowed cleavage by the ribozyme to
produce [+]RNA possessing the authentic MRV M3 3′ end.
Correctness of the construct was verified by DNA sequencing.
The plasmid pBOS36 was used for site-directed mutagenesis
to make the rescue plasmid pBOS36mut. The forward primer
was 5′-GGGTCTATGTCTATACCATATCAACATGTAAA-
TGTTCCAAAAGTTG-3′ and the reverse primer was 5′-CA-Table 1
Forward and reverse primers used to generate M3/μNS mutants
aMutation is named relative to μNS.
bPrimers are written in 5′ to 3′ orientation. Underlined nucleotides indicate changes tha
changes made in some cases to add a restriction enzyme site for screening clones.ACTTTTGGAACATTTACATGTTGATATGGTATAGA-
CATAGACCC-3′. Underlines indicate positions where silent
mutations were made. The region containing the desired mu-
tation was excised with BlpI and NheI and then ligated to
pBOS36 that had been cut with BlpI and NheI to remove the
same region, generating pBOS36mut. Correctness of the sub-
cloned region was verified by DNA sequencing.
To generate rescue constructs with mutations in μNS,
pBOS36mut was used for site-directed mutagenesis, using the
primers in Table 1 and Pfu polymerase (Stratagene) according
to the manufacturer's instructions. For the constructs that ex-
pressed μNS(C561S), μNS(H569Q), μNS(H570Q), and μNS
(C572S), the region containing the desired mutation was ex-
cised with HindIII and BsrGI and then ligated into pBOS36mut
that had been cut with HindIII and BsrGI to remove the same
region. For the constructs that expressed μNS(1–713) or μNS
(1–719), the site-directed mutagenesis protocol was used to
delete the nucleotides that encoded amino acids 714–721 or
720–721. The region containing the desired mutation was
excised with XhoI and BsrGI and then ligated into pBOS36mut
that had been cut with XhoI and BsrGI to remove the same
region. The ΔAUG1 construct mutated the first Met codon,
Met1, to Lys, and the ΔAUG2 construct mutated the second
Met codon, Met41, to Leu. These constructs were subcloned by
excising the region containing the desired mutation with MfeI
and SphI followed by ligation into pBOS36mut that had been
cut with MfeI and SphI to remove the same region. Correctness
of each subcloned region was verified by DNA sequencing.
In vitro transcriptions
Following confirmation of the sequence, pBOS36 was li-
nearized with NotI and used to template MRV M3 [+]RNAt lead to a change in the encoded amino acid, and double underlines indicate silent
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were performed using the AmpliCap-Max T7 High Yield
Message Maker Kit (Epicentre). The protocol for addition of 5′
caps was according to the manufacturer's instructions. RNA
was precipitated by addition of one volume of 5 M ammonium
acetate. The pelleted RNAwas washed in 70% ethanol, dried,
and resuspended in 40 μl of diethylpyrocarbonate-treated
water.
Transfections and infections
For electroporations, cells were trypsinized, pelleted, and
resuspended in 400 μl OptiMEM (Invitrogen) along with
siRNA as described. The suspension was placed in a 4-mm
cuvette and treated at 220 V, 950 μF, and 0 Ω with a BioRad
Gene Pulser II electoporator. Time constants were routinely
between 25 and 30 ms. Electroporated cells were resuspended in
DMEM containing 10% fetal bovine serum and plated in 6-well
plates for recovery at 37 °C. At 24 h p.t., cells were infected
with purified virions at an MOI of 5 or 10 PFU/cell diluted in
phosphate-buffered saline (PBS) (137 mM NaCl, 3 mM KCl,
8 mM Na2HPO4, 1 mM KH2PO4). The virus was adsorbed at
room temperature for 1 h and removed before fresh medium was
added. Cells were further incubated at 37 °C until harvested at
specified times p.i. For lipofections, cells were transfected with
reovirus cores (5×109 particles) siRNA, and in vitro-transcribed
RNA (1 μg) in 6-well plates with 7 μl of Lipofectamine 2000
(Invitrogen) per well according to the manufacturer's instruc-
tions. Based on the extent to which infectious yields could be
optimally reduced in these experiments, we estimated that
siRNAs were routinely transfected at N99% efficiency. Based on
the numbers of cells expressing viral proteins as observed by
microscopy, we estimated that cores and in vitro-transcribed M3
[+]RNAs were routinely transfected at N50% efficiency.
Immunoblot analysis
Whole-cell lysates were collected at specified times p.i. or
p.t. Cells were washed once in PBS. Addition of 2× sample
buffer (250 mM Tris at pH 8.0, 20% glycerol, 2% SDS, 4%
β-mercaptoethanol, 0.002% bromophenol blue) containing 1×
protease inhibitors (Roche) was used to collect and lyse cells.
Samples were boiled for 5 min and resolved by 10% SDS/
PAGE. Proteins were electroblotted from the gels to nitrocellu-
lose in 25 mM Tris and 192 mM glycine (pH 8.3). Binding of
primary antibodies was detected with horseradish peroxidase-
conjugated antibodies and enhanced chemiluminescence re-
agents (PerkinElmer).
dsRNA analysis
Cell lysates were collected at specified times p.i. using
TrizolLS reagent (Invitrogen) according to the manufacturer's
instructions. Samples were heated to 60 °C for 5 min, and
reovirus dsRNAs were separated by 10% SDS/PAGE. The gel
was stained with 0.5 μg/ml ethidium bromide in TAE buffer
(40 mM Tris acetate, pH 8.3, 1 mM EDTA).Immunofluorescence microscopy
Cells were fixed for 10 min at room temperature in 2%
paraformaldehyde in PBS. Fixed cells were washed three times in
PBS, then permeabilized and blocked in PBS containing 1%
bovine serum albumin and 0.1% Triton X-100 (PBSAT). Primary
antibodies were diluted in PBSAT and incubated with cells for
45min at 37 °C. After three washes in PBS, secondary antibodies
diluted in PBSATwere added and incubated with cells for 30 min
at 37 °C. Cover slips were incubated with 300 nM 4,6-diamidino-
2-phenylindole (Molecular Probes) in PBS for 10min to counter-
stain cell nuclei, washed once in PBS, and mounted on glass
slideswith ProLong (Molecular Probes). Sampleswere examined
with a 60×, 1.4 NA objective using a Nikon TE-2000U inverted
microscope equipped with phase and fluorescence optics. Images
were collected digitally using a cooled, charge-coupled device
camera (Hamamatsu) and analyzed with Metamorph 6.1
(Molecular Devices). All images were processed and prepared
for presentation using Photoshop 5.5 (Adobe Systems).
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